A new Burnet Institute study finds that introducing a hepatitis C outreach and treatment program in Australian community pharmacies, particularly those offering opioid agonist therapy, could ...
I would like to know your opinion on the hepatitis B vaccine and its pros and cons. I’m a 39-year-old man who is thinking about potentially getting one. — Anon. ANSWER: Hepatitis B is a viral illness ...
I would like to know your opinion on the hepatitis B vaccine and its pros and cons. I'm a 39-year-old man who is thinking about potentially getting one.
Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...
Kenya will pilot a life-saving drug that reduces the span of treatment for Hepatitis C. The new drug, Harvoni, released by pharmaceutical giant Gilead, promises a breakthrough in Hepatitis C ...